Sr. Distinguished Scientist - PSTS Neuroscience Disease Area Lead

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Discovery & Pre-Clinical/Clinical Development

Job Sub Function:

Nonclinical Safety

Job Category:

Scientific/Technology

All Job Posting Locations:

Beerse, Antwerp, Belgium, San Diego, California, United States of America, Spring House, Pennsylvania, United States of America

Job Description:

Sr. Distinguished Scientist - PSTS Neuroscience Disease Area Lead

Job Description

Johnson & Johnson is recruiting for a Sr. Distinguished Scientist - PSTS Neuroscience Disease Area Lead. Location options: Spring House, Pennsylvania, United States of America; Beerse, Antwerp, Belgium; San Diego, California, United States of America.

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine

About the Role

PSTS Disease Area Lead (Sr. Distinguished Scientist) Job Description

The PSTS Disease Area Lead (DAL) (TA arena: Neuroscience) is a scientific leader assigned specifically to a disease area and has responsibility for bringing disease area strategic pipeline knowledge back to PSTS and PSTS teams, end-to-end (discovery through registration). The PSTS DAL along with the PSTS Modality Lead are the primary interfaces between the PSTS organization and leaders in the therapeutic areas (TA) as well as other TA-facing partners in other organizations (e.g. Regulatory affairs, Global Medical Safety, Clinical Pharmacology). The DAL’s primary accountability is for disease-specific scientific strategy and risk stewardship across the portfolio, assuring discovery ROPs and competitive development ADPs that incorporate disease area specific considerations and requirements through a PSTS lens.

They will own and evolve strategic project planning frameworks (class risks, translational signals, and platform learnings) and assure PSTS programs are planned consistently across the disease area. This will require ongoing learning with an adaptive/evolving mindset to cover current and future cutting-edge learnings within the disease areas. The DAL has significant scientific expertise in drug development, regulatory sciences, and has specialized knowledge and passion for the disease area that they bring to PSTS teams. The DAL will interact with TA leadership in appropriate TA and governance forums and as needed to stand in, as delegate for PSTS GLT on projects & strategy discussions in TA area.

With the PSTS modality lead(s), the DAL is accountable for recommendations for diligence in TA disease area spaces and for strategic planning in partnership with specific PSTS laboratory functional leaders and external CRO partners as relevant to TA space. The DAL will serve as a coach and mentor for PSTS team leaders working in their portfolio including providing expert advice and review of PSTS plans and regulatory submissions at assigned stages and PSTS functional reviews with the purpose of assuring scientific and regulatory questions are proactively addressed. The DAL is expected to maintain scientific depth and expert working knowledge of competitive intelligence and regulatory landscape in TA arena and to tracks milestones, issues, and attrition and should highlight strategic gaps in PSTS for action for TA area.

The DAL may also serve as the PSTS team lead as needed. The DAL sits as a member of the extended PSTS portfolio leadership team (with GLT, other DALs, modality leads, and DPC members) and will lead or participate in special strategic projects as needed. Drives strategic planning for PSTS preparedness to operate in the designated therapeutic disease area space, including PSTS discovery project plans and development ADPs. DALS will provide executive level updates to management, fostering cross-functional cohesion (within PSTS and between PSTS and other relevant functions), cross-industry activities and forums with regulators and external experts.

Required

…